813 related articles for article (PubMed ID: 23747787)
1. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
[TBL] [Abstract][Full Text] [Related]
2. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
Zimarino M; Ricci F; Romanello M; Di Nicola M; Corazzini A; De Caterina R
Catheter Cardiovasc Interv; 2016 Jan; 87(1):3-12. PubMed ID: 25846673
[TBL] [Abstract][Full Text] [Related]
3. Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Nagaraja V; Ooi SY; Nolan J; Large A; De Belder M; Ludman P; Bagur R; Curzen N; Matsukage T; Yoshimachi F; Kwok CS; Berry C; Mamas MA
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27986755
[TBL] [Abstract][Full Text] [Related]
4. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
[TBL] [Abstract][Full Text] [Related]
5. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
6. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
[TBL] [Abstract][Full Text] [Related]
7. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
[TBL] [Abstract][Full Text] [Related]
9. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
[TBL] [Abstract][Full Text] [Related]
11. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
[TBL] [Abstract][Full Text] [Related]
12. Multivessel Coronary Revascularization Strategies in Patients with Chronic Kidney Disease: A Meta-Analysis.
Wu P; Luo F; Fang Z
Cardiorenal Med; 2019; 9(3):145-159. PubMed ID: 30844786
[TBL] [Abstract][Full Text] [Related]
13. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
14. Impact of Complete or Incomplete Revascularization for Left Main Coronary Disease: The Extended PRECOMBAT Study.
Kim T; Kang DY; Kim S; Lee JH; Kim AR; Lee Y; Oh HJ; Jang M; Lee J; Kim JH; Lee PH; Ahn JM; Park SJ; Park DW;
JACC Asia; 2023 Feb; 3(1):65-74. PubMed ID: 36873760
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
Huang F; Lai W; Chan C; Peng H; Zhang F; Zhou Y; Teng S; Huang Z
Cardiol J; 2015; 22(2):123-34. PubMed ID: 24846507
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
Al Ali J; Franck C; Filion KB; Eisenberg MJ
JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis Comparing the Risk of Myocardial Infarction Following Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Multivessel or Left Main Coronary Artery Disease.
Lee PH; Park H; Lee JS; Lee SW; Lee CW
Am J Cardiol; 2019 Sep; 124(6):842-850. PubMed ID: 31311660
[TBL] [Abstract][Full Text] [Related]
18. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
El-Hayek GE; Gershlick AH; Hong MK; Casso Dominguez A; Banning A; Afshar AE; Herzog E; Tamis-Holland JE
Am J Cardiol; 2015 Jun; 115(11):1481-6. PubMed ID: 25840579
[TBL] [Abstract][Full Text] [Related]
20. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
